|
US Pregnancy & Ovulation Test Kits 2004
|
| Snapshots International | 12 pages | Novembre 2004 | Anglais
| |
Snapdata's US Pregnancy & Ovulation Test Kits 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US pregnancy a ... |
240,00 € |
| |
| |
|
|
| |
|
|
Millennium Pharmaceuticals, Inc. - SWOT Analysis
|
| Datamonitor | 22 pages | Mai 2007 | Anglais
| |
Datamonitor's Millennium Pharmaceuticals, Inc.
- SWOT Analysis Company Profile is the essential source for top-level company data and information.
The report examines the company’s key business ... |
100,00 € |
| |
| |
|
|
| |
|
|
OTC Pharmaceuticals in Asia-Pacific
|
| Datamonitor | 14 pages | Janvier 2006 | Anglais
| |
Datamonitor's OTC Pharmaceuticals in Asia-Pacific industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry.
It includes detailed data on m ... |
160,00 € |
| |
| |
|
|
| |
|
|
Snapshots Ukraine Pharmaceuticals 2008
|
| Snapshots International | 14 pages | Mars 2008 | Anglais
| |
Snapdata's Snapshots Ukraine Pharmaceuticals 2008 provides 2007 year-end market size data, with 2008 estimates, 4 years of historical data and five-year forecasts.
The Snapshots report gives an ins ... |
248,00 € |
| |
| |
|
|
| |
|
|
|
|
Emerging pharmaceutical markets Argentina and Mexico
|
| Datamonitor | 106 pages | Mars 2008 | Anglais
| |
IntroductionLatin American countries have attracted a lot of attention recently.
With their economies currently stable, their geographic location and low-cost is ideal for investors.
In addition ... |
6.080,00 € |
| |
| |
|
|
| |
|
|
Dow Chemical: Company Analysis
|
| Rocsearch | 40 pages | Février 2006 | Anglais
| |
This report provides a comprehensive analysis about the company.
Starting with the company’s history, including its organizational set-up and description of its businesses, the report moves on to d ... |
535,00 € |
| |
| |
|
|
| |
|
|
Lipitor case study: Lifecycle management strategies
|
| Datamonitor | 13 pages | Novembre 2005 | Anglais
| |
Since its launch, Lipitor has become the leading cholesterol-lowering drug in the US and the most widely prescribed drug in the world.
However, numerous generic based statins and statin-based combi ... |
250,75 € |
| |
| |
|
|
| |
|
|
Disease and Therapy Review: High Cholesterol
|
| Timely Data Resources | 7 pages | Août 2006 | Anglais
| |
| The High Cholesterol Disease and Therapy Review provides prevalence numbers and percentages for major countries worldwide, information on risk categories, and an overview of treatments, including niac ... |
720,00 € |
| |
| |
|
|
| |
|
|
Chinese Markets for Cardiovascular Drugs
|
| Amid Co | 235 pages | Octobre 2002 | Anglais
| |
China's demand for cardiovascular drugs has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's eco ... |
2.835,00 € |
| |
| |
|
|
| |
|
